Glenmark Pharmaceuticals, USA, has announced the commercial launch of its epinephrine injection USP, 30 mg/30 mL (1 mg/mL) multiple-dose epinephrine vial in the US pharmaceutical market. The product expands Glenmark’s hospital injectables portfol...
Practo, a digital healthcare platform, plans to hit $1 billion in yearly gross merchandise value (GMV) by June 2026.
Emcure Pharmaceuticals is launching Poviztra, a new version of Novo Nordisk’s GLP-1 weight management drug, in India. This move increases Emcure's role in the quickly growing market for obesity treatments
Bharat Biotech signs a tech transfer deal with Biofabri to develop and supply the MTBVAC tuberculosis vaccine, supporting global TB control and Phase III trials.
The Indian Pharmaceutical Alliance (IPA) has revealed $15 million expenditure to build a dedicated pharmaceutical quality institute in Ahmedabad.
Merck has revealed a historic deal with the American government meant to increase prescription drug access for American consumers while simultaneously lowering costs.
The Most Favoured Nation (MFN) drug pricing policy proposed in the United States is not expected to have an immediate impact on Indian pharmaceutical companies, according to industry analysts and market experts. The policy seeks to align US prescr...
Cipla partners with Pfizer to exclusively market five established brands in India, strengthening acute therapy presence and expanding patient access through a nationwide distribution network.
AstraZeneca Pharma India Ltd. (AZPIL) has received approval from the Central Drugs Standard Control Organisation (CDSCO) to import, sell, and distribute datopotamab deruxtecan (Dato-DXd) in India for the treatment of metastatic breast cance...
Senores Pharmaceuticals acquires Apnar Pharma in a move that strengthens its footprint across regulated global markets. The company has signed a definitive agreement to acquire a 100 percent equity stake in Apnar Pharma Private Limited, along...